Cite
Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year Experience.
MLA
Habashy, David, et al. “Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-Institute, Multi-Energy 15-Year Experience.” The Journal of Urology, vol. 210, no. 1, July 2023, pp. 108–16. EBSCOhost, https://doi.org/10.1097/JU.0000000000003443.
APA
Habashy, D., Reddy, D., Peters, M., Shah, T. T., van Son, M., van Rossum, P. S. N., Tanaka, M. B., Cullen, E., Engle, R., McCracken, S., Greene, D., Hindley, R. G., Emara, A., Nigam, R., Orczyk, C., Shergill, I., Persad, R., Virdi, J., Moore, C. M., … Dudderidge, T. (2023). Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year Experience. The Journal of Urology, 210(1), 108–116. https://doi.org/10.1097/JU.0000000000003443
Chicago
Habashy, David, Deepika Reddy, Max Peters, Taimur T Shah, Marieke van Son, Peter S N van Rossum, Mariana Bertoncelli Tanaka, et al. 2023. “Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-Institute, Multi-Energy 15-Year Experience.” The Journal of Urology 210 (1): 108–16. doi:10.1097/JU.0000000000003443.